Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help

Arta M Monjazeb, Julia K. Tietze, Steven K. Grossenbacher, Hui Hua Hsiao, Anthony E. Zamora, Annie Mirsoian, Brent Koehn, Bruce R. Blazar, Jonathan M. Weiss, Robert H. Wiltrout, Gail D. Sckisel, William J Murphy

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander- activated" (CD8+CD44high) T cells displaying a CD25-NKG2D+ phenotype in a cytokine dependent manner, which were responsible for the anti-tumor effects. While much attention has focused on CD4+ T cell help for antigen-specific CD8+ T cell expansion, little is known regarding the role of CD4+ T cells in antigen-nonspecific bystander-memory CD8+ T cell expansion. Utilizing CD4 deficient mouse models, we observed a significant expansion of bystander-memory T cells following IT which was similar to the non- CD4 depleted mice. Expanded bystander-memory CD8+ T cells upregulated PD-1 in the absence of CD4+ T cells which has been published as a hallmark of exhaustion and dysfunction in helpless CD8+ T cells. Interestingly, compared to CD8+ T cells from CD4 replete hosts, these bystander expanded cells displayed comparable (or enhanced) cytokine production, lytic ability, and in vivo anti-tumor effects suggesting no functional impairment or exhaustion and were enriched in an effector phenotype. There was no acceleration of the post-IT contraction phase of the bystander memory CD8+ response in CD4-depleted mice. The response was independent of IL-21 signaling. These results suggest that, in contrast to antigen-specific CD8+ T cell expansion, CD4+ T cell help is not necessary for expansion and activation of antigen-nonspecific bystander-memory CD8+ T cells following IT, but may play a role in regulating conversion of these cells from a central memory to effector phenotype. Additionally, the expression of PD-1 in this model appears to be a marker of effector function and not exhaustion.

Original languageEnglish (US)
Article numbere102709
JournalPLoS One
Volume9
Issue number8
DOIs
StatePublished - Aug 13 2014

Fingerprint

T-cells
immunotherapy
interleukin-2
Immunotherapy
Interleukin-2
Tumors
T-lymphocytes
Chemical activation
T-Lymphocytes
neoplasms
Neoplasms
Data storage equipment
antigens
Antigens
CD8 Antigens
Phenotype
phenotype
cytokines
Cytokines
mice

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help. / Monjazeb, Arta M; Tietze, Julia K.; Grossenbacher, Steven K.; Hsiao, Hui Hua; Zamora, Anthony E.; Mirsoian, Annie; Koehn, Brent; Blazar, Bruce R.; Weiss, Jonathan M.; Wiltrout, Robert H.; Sckisel, Gail D.; Murphy, William J.

In: PLoS One, Vol. 9, No. 8, e102709, 13.08.2014.

Research output: Contribution to journalArticle

Monjazeb, AM, Tietze, JK, Grossenbacher, SK, Hsiao, HH, Zamora, AE, Mirsoian, A, Koehn, B, Blazar, BR, Weiss, JM, Wiltrout, RH, Sckisel, GD & Murphy, WJ 2014, 'Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help', PLoS One, vol. 9, no. 8, e102709. https://doi.org/10.1371/journal.pone.0102709
Monjazeb, Arta M ; Tietze, Julia K. ; Grossenbacher, Steven K. ; Hsiao, Hui Hua ; Zamora, Anthony E. ; Mirsoian, Annie ; Koehn, Brent ; Blazar, Bruce R. ; Weiss, Jonathan M. ; Wiltrout, Robert H. ; Sckisel, Gail D. ; Murphy, William J. / Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help. In: PLoS One. 2014 ; Vol. 9, No. 8.
@article{10cb31ccdbde48ee93780ecbd548ca32,
title = "Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help",
abstract = "We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent {"}bystander- activated{"} (CD8+CD44high) T cells displaying a CD25-NKG2D+ phenotype in a cytokine dependent manner, which were responsible for the anti-tumor effects. While much attention has focused on CD4+ T cell help for antigen-specific CD8+ T cell expansion, little is known regarding the role of CD4+ T cells in antigen-nonspecific bystander-memory CD8+ T cell expansion. Utilizing CD4 deficient mouse models, we observed a significant expansion of bystander-memory T cells following IT which was similar to the non- CD4 depleted mice. Expanded bystander-memory CD8+ T cells upregulated PD-1 in the absence of CD4+ T cells which has been published as a hallmark of exhaustion and dysfunction in helpless CD8+ T cells. Interestingly, compared to CD8+ T cells from CD4 replete hosts, these bystander expanded cells displayed comparable (or enhanced) cytokine production, lytic ability, and in vivo anti-tumor effects suggesting no functional impairment or exhaustion and were enriched in an effector phenotype. There was no acceleration of the post-IT contraction phase of the bystander memory CD8+ response in CD4-depleted mice. The response was independent of IL-21 signaling. These results suggest that, in contrast to antigen-specific CD8+ T cell expansion, CD4+ T cell help is not necessary for expansion and activation of antigen-nonspecific bystander-memory CD8+ T cells following IT, but may play a role in regulating conversion of these cells from a central memory to effector phenotype. Additionally, the expression of PD-1 in this model appears to be a marker of effector function and not exhaustion.",
author = "Monjazeb, {Arta M} and Tietze, {Julia K.} and Grossenbacher, {Steven K.} and Hsiao, {Hui Hua} and Zamora, {Anthony E.} and Annie Mirsoian and Brent Koehn and Blazar, {Bruce R.} and Weiss, {Jonathan M.} and Wiltrout, {Robert H.} and Sckisel, {Gail D.} and Murphy, {William J}",
year = "2014",
month = "8",
day = "13",
doi = "10.1371/journal.pone.0102709",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help

AU - Monjazeb, Arta M

AU - Tietze, Julia K.

AU - Grossenbacher, Steven K.

AU - Hsiao, Hui Hua

AU - Zamora, Anthony E.

AU - Mirsoian, Annie

AU - Koehn, Brent

AU - Blazar, Bruce R.

AU - Weiss, Jonathan M.

AU - Wiltrout, Robert H.

AU - Sckisel, Gail D.

AU - Murphy, William J

PY - 2014/8/13

Y1 - 2014/8/13

N2 - We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander- activated" (CD8+CD44high) T cells displaying a CD25-NKG2D+ phenotype in a cytokine dependent manner, which were responsible for the anti-tumor effects. While much attention has focused on CD4+ T cell help for antigen-specific CD8+ T cell expansion, little is known regarding the role of CD4+ T cells in antigen-nonspecific bystander-memory CD8+ T cell expansion. Utilizing CD4 deficient mouse models, we observed a significant expansion of bystander-memory T cells following IT which was similar to the non- CD4 depleted mice. Expanded bystander-memory CD8+ T cells upregulated PD-1 in the absence of CD4+ T cells which has been published as a hallmark of exhaustion and dysfunction in helpless CD8+ T cells. Interestingly, compared to CD8+ T cells from CD4 replete hosts, these bystander expanded cells displayed comparable (or enhanced) cytokine production, lytic ability, and in vivo anti-tumor effects suggesting no functional impairment or exhaustion and were enriched in an effector phenotype. There was no acceleration of the post-IT contraction phase of the bystander memory CD8+ response in CD4-depleted mice. The response was independent of IL-21 signaling. These results suggest that, in contrast to antigen-specific CD8+ T cell expansion, CD4+ T cell help is not necessary for expansion and activation of antigen-nonspecific bystander-memory CD8+ T cells following IT, but may play a role in regulating conversion of these cells from a central memory to effector phenotype. Additionally, the expression of PD-1 in this model appears to be a marker of effector function and not exhaustion.

AB - We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander- activated" (CD8+CD44high) T cells displaying a CD25-NKG2D+ phenotype in a cytokine dependent manner, which were responsible for the anti-tumor effects. While much attention has focused on CD4+ T cell help for antigen-specific CD8+ T cell expansion, little is known regarding the role of CD4+ T cells in antigen-nonspecific bystander-memory CD8+ T cell expansion. Utilizing CD4 deficient mouse models, we observed a significant expansion of bystander-memory T cells following IT which was similar to the non- CD4 depleted mice. Expanded bystander-memory CD8+ T cells upregulated PD-1 in the absence of CD4+ T cells which has been published as a hallmark of exhaustion and dysfunction in helpless CD8+ T cells. Interestingly, compared to CD8+ T cells from CD4 replete hosts, these bystander expanded cells displayed comparable (or enhanced) cytokine production, lytic ability, and in vivo anti-tumor effects suggesting no functional impairment or exhaustion and were enriched in an effector phenotype. There was no acceleration of the post-IT contraction phase of the bystander memory CD8+ response in CD4-depleted mice. The response was independent of IL-21 signaling. These results suggest that, in contrast to antigen-specific CD8+ T cell expansion, CD4+ T cell help is not necessary for expansion and activation of antigen-nonspecific bystander-memory CD8+ T cells following IT, but may play a role in regulating conversion of these cells from a central memory to effector phenotype. Additionally, the expression of PD-1 in this model appears to be a marker of effector function and not exhaustion.

UR - http://www.scopus.com/inward/record.url?scp=84905919686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905919686&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0102709

DO - 10.1371/journal.pone.0102709

M3 - Article

C2 - 25119341

AN - SCOPUS:84905919686

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e102709

ER -